Naproxen
Naproxen sodium
Brand names:Aleve, Naprosyn, Anaprox
A long-acting non-steroidal anti-inflammatory drug (NSAID) used for mild to moderate musculoskeletal and inflammatory pain. Naproxen's primary operational advantage over ibuprofen is its 12-hour dosing interval, which reduces pill burden during sustained operations and training cycles. Available OTC at 220 mg and by prescription at higher strengths.
Pharmacology and Actions
Naproxen produces analgesic, antipyretic, and anti-inflammatory effects through non-selective inhibition of cyclooxygenase enzymes COX-1 and COX-2, which blocks prostaglandin synthesis at peripheral and central sites. Like other NSAIDs, naproxen also reversibly inhibits platelet aggregation through COX-1 inhibition in platelets, though less profoundly than aspirin. The long half-life of 12 to 17 hours supports twice-daily dosing.
Indications
- Mild to moderate musculoskeletal pain
- Inflammatory pain and sprains
- Dysmenorrhea
- Fever reduction
- Operational chronic-use NSAID alternative to ibuprofen for sustained training or operations
Absolute Contraindications
- Known hypersensitivity to naproxen or other NSAIDs
- Aspirin-induced asthma or prior NSAID-induced bronchospasm
- Active GI bleeding or peptic ulcer disease
- Severe renal impairment
- Third trimester pregnancy (premature closure of ductus arteriosus)
- Perioperative coronary artery bypass graft (CABG) period
Precautions and Side Effects
Common: dyspepsia, heartburn, abdominal pain, nausea. GI bleeding and ulceration risk is cumulative with chronic use; risk is similar to ibuprofen per total exposure despite lower per-dose frequency. Renal: acute kidney injury, fluid retention, hypertension, especially with concurrent ACE inhibitors or diuretics. Cardiovascular: increased MI and stroke risk with chronic use (FDA boxed warning class effect). CNS: headache, dizziness, drowsiness. Hematologic: prolonged bleeding time. Drug interactions: increased bleeding risk with anticoagulants, antiplatelet agents, and SSRIs; reduced antihypertensive effect of ACE inhibitors, ARBs, and diuretics; increased lithium and methotrexate levels; additive GI risk with corticosteroids. Half-life 12 to 17 hours, extending in elderly and renal impairment. Avoid in third trimester pregnancy. Compatible with lactation at OTC doses. Monitor renal function, blood pressure, and GI symptoms with chronic use. Pair with food or milk to reduce GI irritation.
Adult Dosing
Pediatric Dosing
Children 12 years and older: same as adult OTC dosing (220 mg every 8 to 12 hours, max 660 mg per 24 hours). Children 2 to 12 years (prescription, juvenile arthritis): 5 to 7 mg/kg PO every 12 hours. Not recommended OTC under 12 years.
Pharmacokinetics
Peak Effect: 1 to 2 hours (immediate-release).
Duration: 8 to 12 hours - the main operational advantage over ibuprofen.
Storage and Handling
Store at room temperature (20 to 25 degrees C). Protect from moisture. No refrigeration required. Tablet formulations are stable in operational environments including aid bags and IFAKs.
Reconstitution:
Oral formulation only. No reconstitution required.
TCCC and TECC Role
Naproxen is not a TCCC core agent. TCCC 2026 Mild Pain step lists meloxicam plus acetaminophen as the preferred combat wound medication pack (CWMP). Naproxen appears in tactical EMS supplemental formularies as an OTC alternative for chronic musculoskeletal complaints when ibuprofen is being avoided or when longer dosing interval is preferred. In TECC settings, naproxen is appropriate for non-traumatic musculoskeletal pain when the patient is otherwise stable and oral intake is appropriate. It is not a substitute for the TCCC analgesic ladder in acute trauma.
Naproxen's operational niche is the longer duration of action compared with ibuprofen. Twelve-hour dosing means fewer pill burdens during sustained operations or training cycles. Some operators carry naproxen for chronic overuse injuries (knees, shoulders, lower back) where the every-six-to-eight-hour ibuprofen schedule becomes impractical. For acute trauma pain in the tactical care window, TCCC's meloxicam plus acetaminophen combination is doctrine and naproxen is not a TCCC substitute. Best used for chronic musculoskeletal pain in operators who tolerate NSAIDs well and have no contraindications.
Stacking naproxen with ibuprofen or aspirin under the assumption that different NSAIDs produce additive analgesia without additive risk. The risk of GI bleeding and renal injury is cumulative across NSAIDs. The other common mistake is using naproxen for acute hemorrhage scenarios; like all NSAIDs, it impairs platelet function and is contraindicated when active hemorrhage is a concern.
This drug profile is provided as educational reference material for trained medical providers. It is not medical advice, not a substitute for formal training, and not a substitute for current published guidelines or medical direction.
Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances are subject to additional handling, accountability, and documentation requirements per DEA and state law. Always verify dosing, indications, contraindications, and route of administration against current published guidelines and your local protocols before administration.
If this content is being viewed during a medical emergency, call 911 immediately and follow the direction of your local emergency dispatch and medical control. Do not use this reference as a substitute for emergency medical services.
Drug information evolves. Last reviewed dates and source citations are provided for each entry. Confirm currency against the cited source before clinical use.
Penn Tactical Solutions publishes this reference for educational purposes. PTS does not provide medical direction and does not assume responsibility for clinical decisions made in the field. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Educational reference for trained medical providers. Not medical advice. Not a substitute for formal training, current published guidelines, or medical direction. Drug administration is governed by your scope of practice, agency standing orders, medical director protocols, and applicable state and federal regulations. Controlled substances require additional storage, accountability, and documentation per DEA and state law.
In a medical emergency, call 911. This reference is not a substitute for emergency medical services.
Verify dosing, indications, and contraindications against current published guidelines and your local protocols before administration. Confirm content currency against the source citation. Penn Tactical Solutions does not provide medical direction. Clinical responsibility rests with the administering provider, their medical director, and their agency.
Naproxen
| IV/IO | None (None) |
| IM | None (None) |
| IN | None (None) |
| PO | OTC: 220 mg PO every 8 to 12 hours; initial dose may be 440 mg, then 220 mg every 8 to 12 hours; maximum 660 mg per 24 hours. Prescription: 250 to 500 mg PO twice daily; maximum 1500 mg per 24 hours short-term, 1000 mg per 24 hours for chronic use. Take with food or milk to reduce GI irritation. (30 to 60 minutes) |